Plastics in healthcare

Plastic materials are essential in all areas of healthcare, from the most basic products, such as plasters, to the most advanced medical devices. Their use in medicine has helped improve patients’ quality of life, reduce costs and increase hygiene. Innovation in biopolymers, i.e. materials for pharmaceutical and medical use in conjunction with biological systems, presents infinite possibilities in the field of health.

Featured posts on Plastics in healthcare

AIMPLAS develops rapid antibody test that is more sensitive than commercial tests in detecting immunity to SARS-CoV-2 and UK variant

AIMPLAS develops rapid antibody test that is more sensitive than commercial tests in detecting immunity to SARS-CoV-2 and UK variant

A project managed by AIMPLAS has developed a new process for producing rapid COVID-19 tests. According to clinical trials in patients, the test can detect antibodies, as well as the UK variant, with a sensitivity of over 98%.

AIMPLAS makes its resources and production capacity available in the fight against COVID-19 and has designed a new mask with replaceable filters

AIMPLAS makes its resources and production capacity available in the fight against COVID-19 and has designed a new mask with replaceable filters

Given the health emergency generated by the COVID-19 pandemic, AIMPLAS is working to make its knowledge of materials, its capacity for design, prototyping and manufacture, […]

Antibacterial Film Based on Essential Oils for Hospital Use

Antibacterial Film Based on Essential Oils for Hospital Use

The European FLEXPOL project has developed an innovative antibacterial plastic film using nanoencapsulated essential oils that is more eco-friendly than current hygienization methods.

All post on Plastics in healthcare

The ALADDIN project will contribute to the integration of additive manufacturing in the health sector

Additive manufacturing, also known as 3D printing, is a disruptive technology with a promising potential in the health sector. The technology has not yet been […]

AIMPLAS develops rapid antibody test that is more sensitive than commercial tests in detecting immunity to SARS-CoV-2 and UK variant

A project managed by AIMPLAS has developed a new process for producing rapid COVID-19 tests. According to clinical trials in patients, the test can detect antibodies, as well as the UK variant, with a sensitivity of over 98%.

New materials and coatings for healthcare will prevent transmission of hospital-acquired infection by microorganisms

The MOBACT project, funded by the Valencian Innovation Agency (AVI), is developing bio-based solutions as an environmentally sustainable alternative to metal in order to fight the current major public health problem of hospital-acquired infection.

AIMPLAS relies on Leistritz know-how to expand its capabilities

Since August a ZSE 18 HP-PH has been in operation inside a clean room ISO7/GMP at AIMPLAS. With the versatile small extruder from German extrusion expert Leistritz Extrusionstechnik GmbH, the research and development

AIMPLAS working to develop quick new blood, urine and fluid tests to detect COVID-19 virus

The technology centre is working on the development of a quick, cost-effective and efficient technique based on the modification of gold nanoparticles to detect antibodies of SARS-CoV-2 or its antigen.